Carboxypeptidase A2
From Wikipedia, the free encyclopedia
Carboxypeptidase A2 (pancreatic)
|
|||||||||||
PDB rendering based on 1aye. | |||||||||||
Available structures: 1aye, 1dtd, 1o6x | |||||||||||
Identifiers | |||||||||||
Symbol(s) | CPA2; | ||||||||||
External IDs | OMIM: 600688 MGI: 3617840 HomoloGene: 37541 | ||||||||||
|
|||||||||||
RNA expression pattern | |||||||||||
Orthologs | |||||||||||
Human | Mouse | ||||||||||
Entrez | 1358 | 232680 | |||||||||
Ensembl | ENSG00000158516 | ENSMUSG00000071553 | |||||||||
Uniprot | P48052 | n/a | |||||||||
Refseq | NM_001869 (mRNA) NP_001860 (protein) |
NM_001024698 (mRNA) NP_001019869 (protein) |
|||||||||
Location | Chr 7: 129.69 - 129.72 Mb | Chr 6: 30.49 - 30.51 Mb | |||||||||
Pubmed search | [1] | [2] |
Carboxypeptidase A2 (pancreatic), also known as CPA2, is a human gene.[1]
Three different forms of human pancreatic procarboxypeptidase A have been isolated. The A1 and A2 forms are monomeric proteins with different biochemical properties. The A2 form of pancreatic procarboxypeptidase acts on aromatic C-terminal residues[1]
[edit] References
[edit] Further reading
- Pascual R, Burgos FJ, Salva M, et al. (1989). "Purification and properties of five different forms of human procarboxypeptidases.". Eur. J. Biochem. 179 (3): 609-16. PMID 2920728.
- Catasús L, Vendrell J, Avilés FX, et al. (1995). "The sequence and conformation of human pancreatic procarboxypeptidase A2. cDNA cloning, sequence analysis, and three-dimensional model.". J. Biol. Chem. 270 (12): 6651-7. PMID 7896805.
- Laethem RM, Blumenkopf TA, Cory M, et al. (1996). "Expression and characterization of human pancreatic preprocarboxypeptidase A1 and preprocarboxypeptidase A2.". Arch. Biochem. Biophys. 332 (1): 8-18. doi: . PMID 8806703.
- García-Sáez I, Reverter D, Vendrell J, et al. (1998). "The three-dimensional structure of human procarboxypeptidase A2. Deciphering the basis of the inhibition, activation and intrinsic activity of the zymogen.". EMBO J. 16 (23): 6906-13. doi: . PMID 9384570.
- Reverter D, García-Sáez I, Catasús L, et al. (1998). "Characterisation and preliminary X-ray diffraction analysis of human pancreatic procarboxypeptidase A2.". FEBS Lett. 420 (1): 7-10. PMID 9450539.
- Reverter D, Fernández-Catalán C, Baumgartner R, et al. (2000). "Structure of a novel leech carboxypeptidase inhibitor determined free in solution and in complex with human carboxypeptidase A2.". Nat. Struct. Biol. 7 (4): 322-8. doi: . PMID 10742178.
- Hayashida S, Yamasaki K, Asada Y, et al. (2000). "Construction of a physical and transcript map flanking the imprinted MEST/PEG1 region at 7q32.". Genomics 66 (2): 221-5. doi: . PMID 10860668.
- Wouters MA, Husain A (2002). "Changes in zinc ligation promote remodeling of the active site in the zinc hydrolase superfamily.". J. Mol. Biol. 314 (5): 1191-207. doi: . PMID 11743734.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899-903. doi: . PMID 12477932.
- Jiménez MA, Villegas V, Santoro J, et al. (2003). "NMR solution structure of the activation domain of human procarboxypeptidase A2.". Protein Sci. 12 (2): 296-305. PMID 12538893.
- Dantas G, Kuhlman B, Callender D, et al. (2003). "A large scale test of computational protein design: folding and stability of nine completely redesigned globular proteins.". J. Mol. Biol. 332 (2): 449-60. PMID 12948494.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121-7. doi: . PMID 15489334.
- Dantas G, Corrent C, Reichow SL, et al. (2007). "High-resolution structural and thermodynamic analysis of extreme stabilization of human procarboxypeptidase by computational protein design.". J. Mol. Biol. 366 (4): 1209-21. doi: . PMID 17196978.